Propionate Inulin Ester for Appetite Control and Insulin Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for obesity and diabetes lack effective and safe methods to regulate appetite, food intake, and insulin sensitivity, with existing pharmacotherapies often having adverse side effects and limited public health applicability.
Innovation Solution
Oral administration of propionate inulin ester, which reduces appetite, food intake, and calorie consumption while improving insulin sensitivity by facilitating the delivery of propionate to the colon, where it is fermented into short-chain fatty acids, stimulating gut peptides like PYY and GLP-1, leading to increased satiety and improved metabolic responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If pharmacotherapy is used to control appetite and weight, then weight loss is achieved, but serious adverse side effects occur
Solution Approach 1:
The patent uses propionate inulin ester as an intermediary substance that delivers propionate to the colon where it is fermented into short-chain fatty acids. This intermediary approach allows appetite control and weight loss without the direct pharmacological side effects, as the active compound is generated locally in the gut rather than systemically administered
Solution Approach 2:
The body's own gut microbiota performs the fermentation of propionate inulin ester to generate short-chain fatty acids and stimulate gut peptides. This self-service mechanism utilizes the body's natural physiological processes to achieve weight control without external pharmacological intervention, thereby avoiding drug-related side effects
2Productivity
If weight loss surgery is performed to treat severe obesity, then significant weight loss is achieved, but high treatment risk is incurred
Solution Approach 1:
Instead of direct surgical intervention, the patent employs propionate inulin ester as a safe intermediary that gradually delivers propionate to the colon. This non-invasive approach achieves weight loss through physiological mechanisms without the high risks associated with surgery
Solution Approach 2:
The patent uses a dietary supplement (propionate inulin ester) that is safe, non-toxic, and can be discontinued without withdrawal effects. This disposable-like approach replaces permanent, high-risk surgical solutions with a temporary, safe nutritional intervention
3Productivity
If existing appetite control methods are used, then food intake is reduced, but public health applicability is limited due to side effects
Solution Approach 1:
The invention leverages the body's natural gut microbiota and physiological processes to control appetite. By using the body's own fermentation capacity to generate active compounds, the treatment is safe for widespread use across diverse populations without pharmacological contraindications
Solution Approach 2:
The patent changes the parameter of substance delivery from systemic pharmacological administration to localized gut fermentation. This parameter change transforms the treatment from a high-risk drug intervention to a safe, food-based approach suitable for public health implementation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Propionate inulin ester effectively reduces food intake and calorie consumption, promotes weight loss, and improves insulin sensitivity with fewer side effects and greater public health applicability compared to existing treatments, as demonstrated by reduced body weight gain and improved metabolic risk factors in clinical trials.
Implementation Method 1
facilitating the delivery of propionate to the colon, where it is fermented into short-chain fatty acids
Data Source
Figure 1
Figure 2A~2C
Figure 3A~3C
AI summary
The invention provides a propionate inulin ester for the reduction of appetite, food intake and/or calorie intake and/or to improve insulin sensitivity in a subject, and for the treatment or prevention of obesity or diabetes. The invention also provides compositions comprising a propionate inulin ester, methods using propionate inulin esters, functional food containing propionate inulin ester and methods of making propionate inulin esters.